Nathan Chadwick
Senior Director, Therapeutic Strategy Lead, Rare Disease
With more than a decade of dedicated experience in clinical research, Nathan Chadwick is well-versed in several therapeutic areas, with a specialized focus in neurology and rare disease. At Worldwide, Nathan is at the forefront of therapeutic strategy for rare disease, leading ongoing efforts with rare disease patient advocacy organizations while working to expand rare disease opportunities, studies, and initiatives.
Ask Nathan a question
Submit an RFP. Ask a Question
Nathan is pivotal to advancing corporate strategies within rare disease, focusing on cultivating relationships with patient advocacy and leveraging patient-centric strategies to streamline trial recruitment. Skilled in patient recruitment and retention strategies, he has considerable experience working collaboratively with cross-functional teams to ensure clinical trial success. His knowledge spans a broad spectrum of therapeutic areas, including autoimmune and inflammatory diseases, cell and gene therapy, musculoskeletal and orthopedic conditions, and more.
As a member of the Association of Project Managers, Nathan boasts extensive experience in project management, holding various positions in the field where he amassed a wealth of therapeutic and clinical expertise. He has established himself as an expert in the design and execution of clinical trials, overseeing numerous trials from protocol development to data analysis and interpretation.
Nathan has a deep understanding of the patient landscape, and he is committed to putting patients first and staying up to date on the latest advancements in the field. He holds a Bachelor of Science with Honors in Clinical and Health Psychology from Bangor University, where he completed his thesis on “Adult Drinking Motivations.”
